Home
Sponsors
Program
Sessions
Open menu
Session 1
Session 2
Session 3
Session 4
Session 6
Session 7
Session 9
Session 10
Session 12
Session 13
Conferences
Open menu
Welcome
Closing Conference
Posters
Open menu
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Round Tables
Open menu
Round Table 1
Round Table 2
Round Table 3
Meeting Policies
Menu
Home
Sponsors
Program
Sessions
Open menu
Session 1
Session 2
Session 3
Session 4
Session 6
Session 7
Session 9
Session 10
Session 12
Session 13
Conferences
Open menu
Welcome
Closing Conference
Posters
Open menu
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Round Tables
Open menu
Round Table 1
Round Table 2
Round Table 3
Meeting Policies
Poster Session 1
May 18 · 10:30 - 12:30
Chairs
Juan Pablo Fededa
IIBio-CONICET, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Vanesa Gottidredi
Instituto Leloir, Buenos Aires, Argentina.
Estrella Levy
Centro de Investigaciones Oncológicas - Fundación Cáncer (FUCA), Buenos Aires, Argentina.
PS1-01.
CDK4/6 inhibitors and antiprogestins: therapeutic combination in breast cancer experimental models with high levels of progesterone receptor isoform A
PS1-02.
Parameters associated with metastatic dissemination are differentially modulated by specific isotypes of the retinoic acid receptor (RARs) in triple negative mammary cancer models
PS1-03.
Effect of 2’-nitroflavone on the expression of receptors associated with EGFR activity in breast cancer cells
PS1-05.
A potential strategy to prevent drug resistance: Chromosome instability can be prevented with no changes in the induction of cell death after Chk1 depletion
PS1-06.
Exploring the role of hyaluronan and CD44 in resistance to ErbB-2-targeted therapies in breast cancer
PS1-07.
GEF-H1 drives tumor formation, motility, invasion and metastasis in breast cancer
PS1-08.
DNA polymerase iota prevents unleashed DNA elongation to promote cell survival and genomic stability
PS1-09.
Generation of a CRISPR/Cas9 EO771-tumor platform to study breast cancer cell – immune system interactions
PS1-10.
E3 UBIQUITIN LIGASE HERC1 REGULATES BREAST CANCER CELLS MIGRATION AND INVASION
PS1-11.
Tristetraprolin (TTP) down-regulation in mammary epithelial cells induces developmental delay and DUSP-6 phosphatase overexpression
PS1-12.
LIVER X RECEPTOR (LXR) activation may affect breast cancer risk through induction of tristetraprolin (TTP) in mamary epithelial cells
PS1-13.
Morphological and histological studies in mammary glands of GH-overexpressing transgenic mice.
PS1-14.
Inhibition of SETD7 methyl-transferase activity impairs mammary epithelial cell differentiation and lactogenesis
PS1-15.
Phenotypic and functional characterization of memory Natural Killer (NKm) cells in patients with Breast Cancer (BC)
PS1-16.
Study of Foxp3 expression in tumor microenvironment and peripheral blood of breast cancer patients
PS1-17.
Perforator flaps in the reconstruction of Breast and thorax burnts
